➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Colorcon
AstraZeneca
Dow
Mallinckrodt

Last Updated: August 14, 2020

DrugPatentWatch Database Preview

Desonide - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for desonide and what is the scope of freedom to operate?

Desonide is the generic ingredient in four branded drugs marketed by Almirall, Cadila, Cosette, Glenmark Pharms, Perrigo New York, Taro, Galderma Labs Lp, Leo Pharma As, Teresina, Fougera Pharms, Teligent Pharma Inc, Aleor Dermaceuticals, Encube Ethicals, Glenmark Pharms Ltd, and Hi Tech, and is included in twenty-three NDAs. There are four patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Desonide has fifty-six patent family members in twenty-four countries.

There are thirty-one drug master file entries for desonide. Twenty-one suppliers are listed for this compound.

Drug Prices for desonide

See drug prices for desonide

Drug Sales Revenue Trends for desonide

See drug sales revenues for desonide

Recent Clinical Trials for desonide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Massachusetts General HospitalPhase 3
NeoStrata Company, Inc.Phase 3
University of California, DavisPhase 1

See all desonide clinical trials

Pharmacology for desonide
Medical Subject Heading (MeSH) Categories for desonide
Paragraph IV (Patent) Challenges for DESONIDE
Tradename Dosage Ingredient NDA Submissiondate
DESONATE GEL;TOPICAL desonide 021844 2010-12-01

US Patents and Regulatory Information for desonide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo New York DESONIDE desonide OINTMENT;TOPICAL 017426-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Teligent Pharma Inc DESONIDE desonide LOTION;TOPICAL 207855-001 Sep 28, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Cosette DESONIDE desonide CREAM;TOPICAL 074027-001 Sep 28, 1992 AB RX No No   Start Trial   Start Trial   Start Trial
Hi Tech DESONIDE desonide OINTMENT;TOPICAL 208836-001 Mar 27, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for desonide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Almirall VERDESO desonide AEROSOL, FOAM;TOPICAL 021978-001 Sep 19, 2006   Start Trial   Start Trial
Leo Pharma As DESONATE desonide GEL;TOPICAL 021844-001 Oct 20, 2006   Start Trial   Start Trial
Almirall VERDESO desonide AEROSOL, FOAM;TOPICAL 021978-001 Sep 19, 2006   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for desonide

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1304992 92401 Luxembourg   Start Trial PRODUCT NAME: CLINDAMYCINE(EN TANT QUE PHOPSHATE DE CLINDAMYCINE)ET TRETINOINE
1304992 C300617 Netherlands   Start Trial PRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322
1304992 474 Finland   Start Trial
1304992 PA2013025 Lithuania   Start Trial PRODUCT NAME: CLINFAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Baxter
Johnson and Johnson
Colorcon
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.